TrialThe Lancet. Microbe2023

Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation.

Sivan Gazit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.